AAAAAA

   
Results: 1-8 |
Results: 8
The tuberculosis trials consortium: A model for clinical trials collaborations
Authors: Weis, S King, B Thompson, SF Shaffer, N Jones, B Puentes, S Silva, C Hershfield, E Izon, G Mangura, B Reichman, L Leus, MC Owens, M Lahart, C Nickson, R Scott, T Awe, R Murphy, AL Weiner, M Engle, M Chaisson, R Sterling, T Hackman, J Wilcox, F Wassler, P Dukes-Hamilton, C Mosher, A Ho, B Reves, R Burman, W Peloquin, C Tapy, J Rom, W Condos, R Sandman, L Bhattacharya, M Fabre, J El-Sadr, W Klein, M Horton, J Quinn, E Pachuki, C Samuel, M Gordin, F Benator, D Sepulveda, D Quinlan-Mauzy, C Kernodle, D McKee, GS Reeves-Hammock, L Bernardo, J Horsburgh, CR Saukkonen, J Murphy, C Schluger, N Burzynski, J Lozano, V Menzies, R Schwartzman, K Pelletier, M Valiquette, C Nolan, C Goldberg, S Stone, M Fitzgerald, M Hernandez, E Peyvandi, B Daley, C Hopewell, P Stanton, B Merrifield, C Donovan, C Hobbs, B Gotting, V Therrien, M Ferrell, S Bozeman, L Broadnax, S Carter, C Dansbury, K Gross, L Henderson, C Jackson, M Khan, A O'Brien, R Sharma, A Villarino, ME Wang, YC Cooksey, R Crawford, J Sikes, D Metchock, B Sheppard, J Woodley, C Jaffe, H Neaton, J Bass, J
Citation: S. Weis et al., The tuberculosis trials consortium: A model for clinical trials collaborations, PUBL HEA RE, 116, 2001, pp. 41-49
Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection
Authors: Cohn, DL O'Brien, RJ Geiter, LJ Gordin, FM Hershfield, E Horsburgh, CR Jereb, JA Jordan, TJ Kaplan, JE Nolan, CM Starke, JR Taylor, Z Villarino, ME Binkin, NJ Bock, NN Castro, KG Chaisson, RE Comstock, RE Dworkin, MS El-Sadr, W Fujiwara, PI Glassroth, JC Godfrey-Faussett, P Goldberger, MJ Hadler, JL Hopewell, PC Iseman, MD Jacobs, RF Land, MA Lobato, MN Menzies, RI Migliori, GB Miller, BI Mwinga, A Nardell, EA Neaton, J Qualls, NL Reichman, LB Rose, DN Salpeter, SR Sawert, H Simone, PM Snider, DE Tsevat, J Vernon, AA Whalen, CC Wilcosky, TC
Citation: Dl. Cohn et al., Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection, AM J R CRIT, 161(4), 2000, pp. S221-S247
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Safer sex strategies for women: The hierarchical model in methadone treatment clinics
Authors: Stein, Z Saez, H El-Sadr, W Healton, C Mannheimer, S Messeri, P Scimeca, MM Van Devanter, N Zimmerman, R Betne, P
Citation: Z. Stein et al., Safer sex strategies for women: The hierarchical model in methadone treatment clinics, J URBAN H, 76(1), 1999, pp. 62-72
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin
Authors: Cohn, DL Fisher, EJ Peng, GT Hodges, JS Chesnut, J Child, CC Franchino, B Gibert, CL El-Sadr, W Hafner, R Korvick, J Ropka, M Heifets, L Clotfelter, J Munroe, D Horsburgh, CR
Citation: Dl. Cohn et al., A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin, CLIN INF D, 29(1), 1999, pp. 125-133
Does directly observed therapy work?
Authors: Burman, WJ El-Sadr, W
Citation: Wj. Burman et W. El-sadr, Does directly observed therapy work?, AM J PUB HE, 89(4), 1999, pp. 600-601
Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia- Reply
Authors: El-Sadr, W
Citation: W. El-sadr, Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia- Reply, N ENG J MED, 340(19), 1999, pp. 1513-1513
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908
Risultati: 1-8 |